DSCAM and breast cancer: Consistent with the literature, we observed a significantly higher expression of DSCAM-AS1 transcript in TCGA breast cancer patient samples and ER/PR-positive T47-D and BT-474 cells than in MDA-MB-231 cells (Fig. 3A, B, Additional file 1: Figure S4).